Glycopyrrolate Injection Solution, 1 mL 0.2 mg/1 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-45
Published August 16, 2017 · Recall initiated: July 14, 2017
Summary
FDA records drug Class II recall D-1067-2017, published August 16, 2017 and initiated July 14, 2017. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 5245 syringes; Lot: Lot #: 9868, BUD: 8/9/2017; 9872, BUD: 8/10/2017; 10318, BUD: 10/7/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cantrell Drug Company
- Distributor
- Nationwide within the US
- Lot
- Lot #: 9868, BUD: 8/9/2017; 9872, BUD: 8/10/2017; 10318, BUD: 10/7/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEphedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAGlycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell DrugAugust 16, 2017
- FDAPhenylephrine HCL in 0.9% Sodium Chloride 10 mL, 1 mg/10 mL (100 mcg/mL) Single-Dose Syringe, Rx Only,August 16, 2017
- FDANeostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
- FDAGlycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell DrugAugust 16, 2017
- FDASuccinylcholine Chloride Injection Solution 10 mL, 200 mg/10 mL (20 mg/mL) Single-Dose Syringe, Rx Only,August 16, 2017
Questions about this recall
Was Glycopyrrolate Injection Solution, 1 mL 0.2 mg/1 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-45 recalled?
Yes. FDA published recall D-1067-2017 on August 16, 2017. Reported hazard: Lack of Sterility Assurance.
What should I do if I have this product?
Voluntary: Firm initiated · Letter